Description: Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.
Home Page: www.oxb.com
Windrush Court
Oxford,
OX4 6LT
United Kingdom
Phone:
44 1865 783 000
Officers
| Name | Title |
|---|---|
| Dr. Frank Mathias | CEO & Director |
| Dr. Lucinda Crabtree Ph.D. | CFO & Director |
| Mr. Thierry Cournez | Chief Operating Officer |
| Ms. Sophia Bolhassan | Head of Investor Relations |
| Ms. Natalie Louise Walter | General Counsel & Company Secretary |
| Ms. Lisa Doman | Chief People Officer |
| Dr. Kyriacos Mitrophanous Ph.D. | Chief Innovation Officer |
| Ms. Kati Hudson | Head of Intellectual Property and Contracts |
| Dr. Sebastien Ribault | Chief Business Officer |
| Mr. Mark Caswell | Site Head of UK Operations |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 227.2727 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 6.8314 |
| Price-to-Sales TTM: | 5.6081 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 834 |